H2020Индивидуална стипендия2016–2019

FCSSSLP · First Chemoselective Synthesis and Structural Studies of Lasso Peptides

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2016-07-05 → 2019-07-04
Финансиране от ЕС
257 191 €
Участници
2
Схема
MSCA-IF-GF

Линиите свързват координатора с партньорите.

Накратко на български

Ласо-пептидите, като например Microcin J25, се изследват чрез нов синтез и структурни анализи. Тези молекули са по-стабилни от обикновените пептиди, което помага за разработването на по-ефективни антибиотици и лекарства срещу рак или вируси.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

First Chemoselective Synthesis and Structural Studies of Lasso Peptides

Resistance to antibiotics is a response of pathogen microorganisms to the use of these drugs. Unfortunately, abuse implies their loss of efficacy. Bacteria stop being sensitive to their effects, being necessary novel generations of antibiotics to combat infections, with the concomitant more toxic to health. The advantages in using peptides as drugs are their high specificity coupled to a large biological activity. They present a great diversity as therapeutic targets (antibiotics/antifungals, antivirals, cancer, etc). However, several difficulties have prevented them from being widely used as drugs. Peptides show low metabolic stability, they are rapidly degraded in vivo by proteases and the most common form of administration is intravenously, which highly prevent its degradation. In principle, these problems should be minimized with lasso-peptides. The rigidity and high packing (lasso-type) endow them with enormous stability against proteolytic degradation, physical/chemical denaturants. The first years of the project, at TSRI and under the guidance of Prof. Baran, we focused on exploring different synthetic methodologies with the final aim of preparing lasso peptides to study their recognition features and eventually their applications as putative drugs. In the last year of the project, carried out at the Center for Cooperative Research in Biosciences (CIC bioGUNE) under the guidance of Professor Jimenez-Barbero, we focused on the study of protein-ligand molecular recognition processes of biomedical interest. In particular, I was trained in the applications of state-of-the-art Nuclear Magnetic Resonance (NMR) techniques and computational methods in this area. Since the target Microcin J25 lasso peptide was elusive and could not be prepared either by organic or enzymatic synthesis, maintaining the essence of the DoA work-packages, we focused on the molecular recognition study of a biologically highly relevant system: the Heparan Sulfate/FGFR Ig2 system, of interest in cancer and inflammation.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The main objective of this project is to promote the use of peptides as potential therapeutic agents. We now know that ribosomal peptides, and specifically lasso peptides, which are biosynthesized by bacteria as agents of defense, show a compact and rigid structure, giving a high stability against physical, chemical and proteolytic degradation. The spectrum of biological activities of these peptides is very wide, acting as antibiotics and also as enzymatic inhibitors, such as the case of the HIV virus protease. Thus, they show a great potential as a therapeutic alternative to existing drugs. To achieve this goal, the project is divided into two distinct parts, to be performed in the two chosen sites, strategically combining the synthetic aspects (TSRI, San Diego) with the structural determination and their involvement in recognition molecular processes (CIB-CSIC, Madrid) .Firstly, synthetic efforts will be made to chemically synthesize the lasso microcin J25 (MccJ25). It will be an extraordinary example of how we, chemists, can use very complex chemoselective reactions, which are usually reserved for biosynthetic enzymes. During the second part of the project, the first structural studies of Lasso peptides-protein complexes will be accomplished using the synergy of combining NMR with computation methods.The selected research centers to achieve this project are: The Scripps Research Institute (TSRI), being the project supervisor Prof. Phil Baran and Centro de Investigaciones Biológicas (CIB-CSIC), with Prof. Jesús Jiménez-Barbero. Both research groups and centers have a well-gained international prestige.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз